We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

58 hedge funds and large institutions have $72.3M invested in AVEO Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

98% more call options, than puts

Call options by funds: $2.75M | Put options by funds: $1.39M

12% more funds holding

Funds holding: 52 → 58 (+6)

13% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 16

22% less capital invested

Capital invested by funds: $92.7M → $72.3M (-$20.4M)

Holders
58
Holders Change
+6
Holders Change %
+11.54%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
14
Reduced
16
Closed
6
Calls
$2.75M
Puts
$1.39M
Net Calls
+$1.36M
Net Calls Change
+$314K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$3.54M
2
Millennium Management
Millennium Management
New York
+$1.23M
3
WVP
Worth Venture Partners
New Jersey
+$811K
4
BC
Birchview Capital
Vermont
+$620K
5
Citadel Advisors
Citadel Advisors
Florida
+$400K

Top Sellers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
-$2.74M
2
OM
Opaleye Management
Massachusetts
-$1.19M
3
Morgan Stanley
Morgan Stanley
New York
-$247K
4
GCP
GSA Capital Partners
United Kingdom
-$218K
5
CSS
Cubist Systematic Strategies
Connecticut
-$207K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
Ancora Advisors
Ohio
$217K – – –
EWM
27
Evercore Wealth Management
New York
$196K – – –
AA
28
ALPS Advisors
Colorado
$187K -$14.6K -2,349 -6%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$184K +$244K +39,298 New
Morgan Stanley
30
Morgan Stanley
New York
$151K -$247K -39,828 -55%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$116K +$7.1K +1,144 +5%
JF
32
Jump Financial
Illinois
$113K +$150K +24,181 New
GC
33
Grimes & Company
Massachusetts
$91K -$14K -2,260 -10%
XT
34
XTX Topco
Cayman Islands
$85K +$112K +18,128 New
Charles Schwab
35
Charles Schwab
California
$81K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$63K +$64.3K +10,360 +330%
SC
37
Shay Capital
New York
$62K +$82.1K +13,243 New
ECM
38
ExodusPoint Capital Management
New York
$53K +$69.9K +11,264 New
PCS
39
Personal CFO Solutions
New Jersey
$47K -$80.6K -13,000 -57%
MOS
40
MGO One Seven
Ohio
$47K – – –
Simplex Trading
41
Simplex Trading
Illinois
$42K -$110K -17,663 -66%
Lazard Asset Management
42
Lazard Asset Management
New York
$35K +$46.8K +7,542 New
UBS Group
43
UBS Group
Switzerland
$31K +$40.2K +6,480 +3,240%
Wells Fargo
44
Wells Fargo
California
$11K +$6 +1 +0%
Osaic Holdings
45
Osaic Holdings
Arizona
$11K +$5.09K +820 +51%
SFG
46
Steward Financial Group
Texas
$9K +$12.4K +2,000 New
CWM
47
CarsonAllaria Wealth Management
Illinois
$7K +$9.24K +1,490 New
EWM
48
Edge Wealth Management
New York
$5K – – –
MCM
49
Magnolia Capital Management
New York
$5K +$6.2K +1,000 New
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$4K – – –
1
2
3

AVEO Hedge Fund Activity: Q4 2021 in Review

58 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q4 2021, worth a combined $72.3M — down 22% from $92.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AVEO positions and 6 closed out — a net gain of 6 holders — while 14 added to existing stakes and 16 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $3.54M. The largest seller was J. Goldman & Co, cutting an estimated $2.74M.

  • 58 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q4 2021, up from 52 in Q3 2021.
  • Funds reported $72.3M of AVEO Pharmaceuticals, Inc. stock for Q4 2021, down 22% quarter-over-quarter.
  • 12 funds opened new AVEO Pharmaceuticals, Inc. positions in Q4 2021 and 6 closed out, a net change of +6 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q4 2021 was AIGH Capital Management, an estimated $3.54M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q4 2021 was J. Goldman & Co, an estimated $2.74M sold.

Based on aggregated 13F filings for Q4 2021.